摘要
髓样细胞触发受体1(TREM-1)是一种在炎性反应的触发及放大过程中具有重要作用的蛋白。TREM-1选择性表达于血液中性粒细胞和单核/巨噬细胞表面,通过与跨膜蛋白DAP12的信号转导系统偶联发挥作用,可放大促炎性细胞因子的释放,因此在感染性疾病、脓毒症、急性胰腺炎等免疫相关疾病的发病中均发挥着重要作用。针对TREM-1进行干预可能为相关疾病提供新的治疗途径。
Triggering receptor expressed on myeloid cells-1(TREM-1) which is expressed on the surface of neutrophils and monocytes/macrophages plays an important role in the activation and amplification of inflammatory response. TREM-1 ,couples to the activation protein of 12 kDa ( DAP12) ,can amplify the release of proinflammatory cytokines, thus play important roles in many immune correlated liseases such as infectious diseases ,sepsis and acute pancreatitis. Interfering in TREM-1 will be a new treatment to relevant diseases.
出处
《医学综述》
2009年第18期2747-2749,共3页
Medical Recapitulate
关键词
髓样细胞触发受体1
炎症
脓毒症
急性胰腺炎
Triggering receptor expressed on myeloid cells-1
Inflammatory
Sepsis
Acute pancreatitis